SYROS PHARMACEUTICALS INC (SYRS)
Institutional ownership reported to the SEC as of Q1 2025, across 26 quarters.
4
Reporting holders
$3.4K
Reported value
0.0%
Held as options
-38
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Baader Bank Aktiengesellschaft | $1.9K | 83,864 | 0.00% | 2q | +279.6%+$1.4K |
| 1492 Capital Management LLC | $1.2K | 39,244 | 0.00% | 10q | HELD |
| XTX Topco Ltd | $290 | 10,053 | 0.00% | 3q | -87.7%-$2.1K |
| ACADIAN ASSET MANAGEMENT LLC | $9 | 329,793 | 0.00% | 5q | +32.2% |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2025 | 4 | $3.4K | 462,954 | 0 | 2 | 1 | 0.0% |
| Q4 2024 | 42 | $1.5M | 4,847,986 | 6 | 8 | 7 | 26.9% |
| Q3 2024 | 63 | $43.5M | 18,819,662 | 8 | 7 | 17 | 6.9% |
| Q2 2024 | 67 | $103.6M | 20,048,544 | 10 | 15 | 11 | 0.1% |
| Q1 2024 | 69 | $109.2M | 20,371,646 | 17 | 16 | 8 | 0.2% |
| Q4 2023 | 55 | $125.9M | 16,482,480 | 16 | 14 | 5 | 0.5% |
| Q3 2023 | 44 | $41.3M | 10,374,900 | 3 | 11 | 7 | 0.8% |
| Q2 2023 | 48 | $28.1M | 8,836,957 | 4 | 9 | 6 | 0.9% |
| Q1 2023 | 48 | $17.3M | 6,396,137 | 13 | 11 | 6 | 1.2% |
| Q4 2022 | 40 | $24.2M | 6,625,732 | 12 | 5 | 6 | 1.5% |
| Q3 2022 | 48 | $62.2M | 9,330,692 | 48 | 0 | 1 | 3.3% |
| Q2 2022 | 61 | $34.2M | 35,568,151 | 11 | 16 | 22 | 0.0% |
| Q1 2022 | 89 | $53.1M | 44,603,251 | 13 | 22 | 31 | 0.1% |
| Q4 2021 | 88 | $167.2M | 51,412,191 | 9 | 29 | 27 | 0.3% |
| Q3 2021 | 98 | $224.8M | 50,124,434 | 15 | 26 | 35 | 0.8% |
| Q2 2021 | 100 | $279.5M | 50,879,355 | 19 | 45 | 20 | 1.3% |
| Q1 2021 | 104 | $480.2M | 63,818,925 | 15 | 44 | 28 | 0.9% |
| Q4 2020 | 101 | $617.4M | 56,682,191 | 23 | 32 | 28 | 0.7% |
| Q3 2020 | 93 | $405.9M | 46,027,816 | 22 | 19 | 33 | 0.0% |
| Q2 2020 | 81 | $465.1M | 44,689,323 | 20 | 35 | 16 | 0.2% |
| Q1 2020 | 67 | $295.3M | 49,807,679 | 11 | 20 | 21 | 0.2% |
| Q4 2019 | 72 | $294.9M | 42,634,963 | 20 | 28 | 13 | 0.3% |
| Q3 2019 | 62 | $447.8M | 43,076,602 | 5 | 23 | 18 | 0.4% |
| Q2 2019 | 68 | $322.5M | 34,864,029 | 15 | 34 | 13 | 0.3% |
| Q1 2019 | 65 | $218.0M | 23,827,870 | 7 | 22 | 20 | 0.1% |
| Q4 2018 | 68 | $125.3M | 22,484,574 | 2 | 0 | 2 | 0.1% |